Galderma

Advancing dermatology for every skin story

[Galderma @galderma]

We delivered net sales of 3.134 billion USD in H1, reinforcing our confidence to raise full-year sales guidance.
Read more: https://t.co/jvdIT40wiN
#AdvancingDermatology #H1results $GALD

[Galderma @galderma]

A new home for our next chapter in the Americas.
Galderma has officially opened its U.S. and Latin America headquarters in Miami — strengthening collaboration and building on our continued investment in U.S. growth.
Read more https://t.co/2yuCHsrFob
#AdvancingDermatology

[Galderma @galderma]

Join Galderma’s analyst call today at 13:00 CEST as we discuss our record-breaking H1 first half 2026 results.
Access the live call here: https://t.co/utlWOVQkOB
A recording will be available after the event.
#AdvancingDermatology #H1results $GALD

[Galderma @galderma]

Alastin® is expanding across Japan, Singapore, South Korea and Taiwan.
Our skincare brand uses proprietary formulations with innovative regenerative science, that support long-term skin health and recovery before and after aesthetic procedures.
https://t.co/wH7bwkiuwF

[Galderma @galderma]

New insights from the world’s most extensive skin quality profiling survey highlight the impact of skin concerns and why more personalized treatment approaches matter.
Learn more: https://t.co/2EEJqWwvwQ

#SkinSciencebyGalderma #AdvancingDermatology

[Galderma @galderma]

Galderma receives U.S. FDA approval of Differin® Epiduo® Acne Gel for over-the-counter use, expanding access to a dermatologist-recommended, prescription-strength acne treatment for ages 12+.
Read more: https://t.co/PExEVUwIvl
#ForUSAudiences
#DifferinEpiduo
#AdvancingDermatology

[Galderma @galderma]

Our Q1 2026 trading update call will take place today, Thursday 23, at 3:30 PM CET. We invite investors to join: https://t.co/utlWOVQkOB.
A recording will be made available after the event.
#AdvancingDermatology #Q1results $GALD

[Galderma @galderma]

We recorded net sales of 1.473 billion USD in Q1, up 25.5% year-on-year at constant currency. Read more about our progress in the press release: https://t.co/zFBRW2wusD
#AdvancingDermatology #Q1results $GALD

[Galderma @galderma]

Galderma introduces ALASTIN’s Regenerating Skin Nectar with TriHex+™, the newest innovation from Alastin, a leader in peptide-based regenerative skincare.
https://t.co/WI0BKxc6e2

[Galderma @galderma]

New interim data from two investigator‑initiated studies, proudly supported by Galderma, highlight the role of Sculptra® and Restylane® in addressing aesthetic changes associated with weight loss medications and menopause.

Read more: https://t.co/tWNZdLj5ux

[Galderma @galderma]

Late-breaking phase II data will be presented at #AAD2026 in children with moderate-to-severe atopic dermatitis.

Learn more: https://t.co/9ET2JxmRdH

#AdvancingDermatology #SkinScienceByGalderma

[Galderma @galderma]

At the @AADskin meeting, 22 abstracts across Therapeutic Dermatology, Injectable Aesthetics and Dermatological Skincare, including late-breaking data in atopic dermatitis, will be presented. #AAD2026

https://t.co/59uLHJsbXW

[Galderma @galderma]

Galderma receives U.S. FDA approval for Restylane® Contour™ for the correction of temple hollowing, expanding its use beyond cheek augmentation and midface contour deficiencies to support facial balance and harmony.

Read more: https://t.co/V6TWRHra4R

#SkinSciencebyGalderma

[Galderma @galderma]

At #AMWC2026, Galderma will showcase data across Sculptra®, Restylane® and other injectable aesthetics products highlighting our holistic, future focused approach to aesthetics innovation.

https://t.co/WNJ5wkrjdX

#AdvancingDermatology #SkinSciencebyGalderma

[Galderma @galderma]

Galderma buys back shares worth CHF 232 million in the context of accelerated bookbuild offering. $GALD
Read more: https://t.co/A32nK1f0Zu

[Galderma @galderma]

Galderma today announced the successful placement of a single-tranche EUR 500 million Eurobond. $GALD
Read more: https://t.co/15hhYholLS

[Galderma @galderma]

Galderma unveils #Cetaphil AM/PM Antioxidant Serums — a science-driven defense + recovery system designed for sensitive skin. Powered by Gallic-AOX Power™ Technology, delivering greater antioxidant efficacy than Vitamin C with visible results in 7 days.
https://t.co/pMnMSe4ZXZ

[Galderma @galderma]

Our FY 2025 trading update call for investors takes place today, Thursday 5 March at 2 PM CET. Join live or watch the recording to learn about our record-breaking performance: https://t.co/utlWOVQkOB.
#AdvancingDermatology #FYResults2025 $GALD

[Galderma @galderma]

FY 2025 results: Galderma achieved record net sales of 5.207 billion USD, surpassing annual sales of 5 billion USD for the first time, growing 17.7% year-on-year at constant currency. Read more: https://t.co/UVsdfm05C1
#AdvancingDermatology #FYResults2025 $GALD

[Galderma @galderma]

Beauty x Medicine returns with special guest Nicolas Hieronimus, CEO of L’Oréal. His four decades in the beauty industry have shown Nicolas that beauty isn’t just about meeting needs, but about “making dreams come true.
Watch the full episode: https://t.co/79OnmcgZq9